HETEROCYCLES, Vol. 77, No. 1, 2009
633
min for 2R,3S-isomer, 17.6 min for 2S,3R-isomer). 7: [α]D24 -16.2 (c 1.18, CHCl3); IR (neat) 3446, 1735,
1
1654 cm-1; H NMR (400 MHz, CDCl3) δ 1.00-2.00 (1H, m), 2.12-2.13 (1H, m), 3.78 (3H, s), 3.79-3.93
13
(1H, m), 5.03 (1H, d, J = 9.3 Hz), 6.83 (1H, d, J = 9.3 Hz), 6.86-7.86 (5H, m); C NMR (100 MHz,
CDCl3) δ 25.66, 25.73, 26.13, 28.75, 29.19, 40.15, 52.65, 54.00, 127.20, 128.62, 131.84, 133.88, 167.53,
172.40. HRMS (FAB) calcd for C17H23NO4: 306.1706(M++1). Found: 306.1718.
(4R,5R)-5-Cyclohexyl-2-phenyl-4,5-dihydrooxazole-4-carboxylic acid methyl ester (9)
Mehod (A): To a cooled stirred solution of 7 (300 mg, 0.982 mmol) in THF (10 mL) at 0 °C was added
dropwise thionyl chloride (79μL, 1.08 mmol) and the mixture was heated to 60 °C for 10 h. After cooling
the mixture to 0 °C, the mixture was carefully quenched with saturated aqueous sodium hydrogen
carbonate. The whole was extracted with EtOAc and the organic layer was washed with water and
saturated brine. After filtration, the filtrate was concentrated in vacuo to give the residue, which was
chromatographed on silica gel (n-hexane/EtOAc = 4/1) to afford the cis-oxazoline (8, 169 mg, 60 %) as a
colorless oil along with the byproduct 9. 8: [α]D20 -75.4 (c 1, CHCl3); IR (neat) 2928, 1746, 1644 cm-1; 1H
NMR (400 MHz, CDCl3) δ 1.09-2.00 (1H, m), 3.79 (1H, m), 4.55 (1H, dd, J = 7.7, 9.7 Hz), 4.94 (1H, d, J
= 9.7 Hz), 7.40-7.53 (3H, m), 7.98-8.00 (2H, m); EI-LRMS 287 (M+); 13C NMR (CDCl3) δ 170.6, 166.6,
131.7, 128.4, 128.2, 127.2, 86.5, 70.4, 52.0, 38.8, 29.8, 28.9, 26.0, 25.7, 25.4. HRMS (FAB) calcd for
C17H21NO3: 288.1593(M++1). Found: 288.1605. The crude 9 was a ca.3:1 mixture of diastereomers and
was chromatographed on silica gel (n-hexane/EtOAc = 2/1) to give the major isomer as a colorless oil. 9
25
1
(major): [α]D -55.5 (c 1.1, CHCl3); IR (neat) 2926, 2853, 1603, 1580 cm-1; H NMR (CDCl3) δ
1.03-2.16 (11H, m), 3.80 (3H, s), 4.33 (1H, dd, J = 2.0 Hz, 9.6 Hz), 5.43 (1H, dd, J = 2.0 Hz, 9.8 Hz),
6.76 (1H, d, J = 10 Hz), 7.47-7.58 (3H, m), 7.82-7.86 (2H, m); 13C NMR (CDCl3) δ 170.6, 166.6, 131.7,
128.4, 128.2, 127.2, 86.5, 70.4, 52.0, 38.8, 29.8, 28.9, 26.0, 25.7, 25.4; HRMS (FAB) calcd for
C17H23ClNO3: 324.1366(M++1). Found: 324.1379.
Method (B): A mixture of 7 (59 mg, 0.193 mmol) and the Burgess reagent (110 mg, 0.46 mmol) in THF
(2.5 mL) was heated to 70 °C for 3 h. After cooling the mixture to rt, the residue was chromatographed on
silica gel (n-hexane/EtOAc = 4/1) to give the cis-oxazoline (9, 34 mg, 62 %) as a colorless oil.
(2R,3R)-2-Amino-3-cyclohexyl-3-hydroxypropionic acid (1)
6 M Aqueous hydrochloric acid (15 mL) was added to 9 (101.5 mg, 0.353 mmol) and the mixture was
heated at reflux for 9.5 h. After cooling the mixture to rt, the mixture was extracted with Et2O. The
aqueous layer was concentrated in vacuo to give the amino acid hydrochloride (1, 105 mg). This crude
hydrochloride was charged on Dowex 50W-X4 ion-exchange resin (20 mL, H+ form). The resin was
eluted with water and then 2 M pyridine aqueous solution. The combined aqueous pyridine fractions were
condensed in vacuo to give the pure amino acid (1, 68 mg, quant) as white powder. The analytical sample
was obtained by precipitation from aqueous MeOH.